Chemistry

YC-Backed Yoneda Labs Raises $4 Million Seed Led by Khosla Ventures to Build Foundation Model for Chemists

Retrieved on: 
Friday, April 26, 2024
Science, Software, Biotechnology, Research, Pharmaceutical, Health, Artificial Intelligence, Technology, University, Machine learning, Khosla Ventures, YC, Literature, Automation, Chemistry, Robotics, University of California, Berkeley, Y Combinator, Drug development, Drug discovery, Running, Algorithm, UC, Pharmaceutical industry

Yoneda Labs , the Y Combinator startup building a foundation model for chemists working in drug discovery, today announced it has raised $4 million in seed capital from Khosla Ventures, 500 Emerging Europe, 468 Capital, Fellows Fund, and Y Combinator.

Key Points: 
  • Yoneda Labs , the Y Combinator startup building a foundation model for chemists working in drug discovery, today announced it has raised $4 million in seed capital from Khosla Ventures, 500 Emerging Europe, 468 Capital, Fellows Fund, and Y Combinator.
  • “At Yoneda, our vision is to build a foundation AI model that analyzes and predicts what will happen before a chemist has to run their experiment.
  • Yoneda Labs was founded by a group from the University of Cambridge with backgrounds in chemistry, robotics, and machine learning.
  • During their time at YC, the team identified 20,000 chemical reactions to generate proprietary data for their foundation model.

Academic Computer Centre Cyfronet AGH launches Poland’s fastest supercomputer built by Hewlett Packard Enterprise

Retrieved on: 
Thursday, April 25, 2024
Semiconductor, Technology, Nanotechnology, Networks, Artificial Intelligence, Hardware, CPU, HPC, Big data, Hewlett Packard Enterprise, Physics, Hospital, AI, Proton therapy, HPE, Research, Wind, Engineering, Science, DLC, Deep learning super sampling, Chemistry, Medicine, DDR5, NVIDIA, NVM Express, GPU, Astronomy, Memory, Data-rate units, Drug discovery, Cray, Video game

Hewlett Packard Enterprise (NYSE: HPE) today announced that it built a new supercomputer for the Academic Computer Centre Cyfronet of the AGH University of Krakow, making it Poland’s fastest system1.

Key Points: 
  • Hewlett Packard Enterprise (NYSE: HPE) today announced that it built a new supercomputer for the Academic Computer Centre Cyfronet of the AGH University of Krakow, making it Poland’s fastest system1.
  • The new system, called Helios, is Cyfronet’s fifth-generation supercomputer and will be used to advance AI-driven scientific research and innovative commercial applications.
  • The supercomputer delivers a theoretical peak performance of 35 petaflops, which is over four times faster than Cyfronet’s previous flagship system.
  • Helios also has a total of 17.5 petabytes of Lustre file system storage built on the HPE Cray ClusterStor E1000 Storage System.

Xaira Therapeutics Launches to Deliver Transformative Medicines by Advancing and Harnessing AI for Drug Discovery and Development

Retrieved on: 
Wednesday, April 24, 2024
Data Management, Health, Technology, Artificial Intelligence, Pharmaceutical, Biotechnology, Ron Conway, Element, Biochemistry, ARCH Venture Partners, AI, Sequoia Capital, Systems biology, Intelligence, SVP, Medicine, Howard Hughes Medical Institute, Drug discovery, Onyx Pharmaceuticals, Food, EVP, R&D, Machine learning, Nobel Prize, NEA, Entrepreneurship, CIO, Boston Consulting Group, Therapy, Lux Capital, Foresite Capital, Executive, Lightspeed Venture Partners, Johnson & Johnson, Proteomics, Meta, Rockefeller University, Chemistry, Biology, Former, Drug development, Menlo Ventures, Interline, Stanford University, University, Food and Drug Administration, Disease, Patient, Senior advisor, Pharmaceutical industry

Xaira Therapeutics launched today on a mission to help re-engineer the way we discover and develop medicines through the end-to-end application of emerging AI technologies.

Key Points: 
  • Xaira Therapeutics launched today on a mission to help re-engineer the way we discover and develop medicines through the end-to-end application of emerging AI technologies.
  • Xaira brings together three core elements: advanced machine learning research, expansive data generation to power new models, and robust therapeutic product development.
  • With leading talent and capabilities in each area, Xaira is building a platform for drug discovery and development that will advance multiple drug programs and unlock biological understanding to inform future discovery.
  • Xaira is building significant AI research capabilities spanning fundamental computational methods development and their application to biological discovery, the design of drug-like matter, and clinical development.

International Dairy Queen Hires New Research and Development Executive

Retrieved on: 
Tuesday, April 23, 2024
Retail, Restaurant, Bar, Other Retail, Food, Beverage, Snack, Food safety, Lead, University, International, Protein, EVP, Cargill, Dairy Queen, Research, IDQ, Cornell University, Chemistry, Friedrich, Multimedia, Drink, Growth, Management

International Dairy Queen, Inc. (IDQ) today announced Jane Friedrich joined the company as executive vice president, research and development, reporting to the president and CEO.

Key Points: 
  • International Dairy Queen, Inc. (IDQ) today announced Jane Friedrich joined the company as executive vice president, research and development, reporting to the president and CEO.
  • View the full release here: https://www.businesswire.com/news/home/20240423449772/en/
    Jane Friedrich, executive vice president, research and development at International Dairy Queen (Photo: Business Wire)
    “Our success is built upon developing and innovating new treat and hot food products that attract new customers and keep existing fans coming back for more,” said Troy Bader, president and CEO at International Dairy Queen.
  • “Jane’s decades of increasingly successful research and development experience paired with leadership in food safety and quality, position her well to lead and grow our global business to the next level.”
    “I am excited to join International Dairy Queen at a time when growth is a strategic business priority,” said Jane Friedrich, EVP, research and development at International Dairy Queen.
  • Friedrich is a published researcher, holds several patents, and serves as the executive chair of the Food Fortification Initiative executive management team.

Sapio Sciences Launches New Multimodal Registration Capabilities For Its Lab Informatics Platform

Retrieved on: 
Tuesday, April 23, 2024
Software, Research, General Health, Pharmaceutical, Data Management, Technology, Genetics, Health Technology, Clinical Trials, Science, Biotechnology, Health, Other Science, Lens, A-DNA, Drug discovery, Molecular biology, Chemistry, Informatics, Peptide, BCG, Fine chemical

Sapio Sciences , the science-aware™ lab informatics platform, today announced the launch of its new multimodal registration capabilities.

Key Points: 
  • Sapio Sciences , the science-aware™ lab informatics platform, today announced the launch of its new multimodal registration capabilities.
  • This new functionality unifies small-molecule, large-molecule, and multimodal discovery workflows, including entity registration, on a single platform.
  • With these latest features, Sapio is helping R&D teams overcome the collaboration and efficiency challenges traditionally associated with the development of multimodal therapies and products.
  • Established biopharma enterprises will want to reassess the limitations and risks of currently deployed separate chemistry- and biology-centric informatics and evaluate the benefits and advantages of a single unified lab informatics platform from Sapio to optimize leading-edge multimodal drug discovery.

“Happy Women” Podcast with Jennifer Horn and Katie Gorka Launches on the Salem Podcast Network

Retrieved on: 
Monday, April 22, 2024
Women, Entertainment, Religion, Communications, General Entertainment, TV and Radio, Digital Marketing, Consumer, Podcast, Knowledge, Salem Media Group, The Heritage Foundation, Radio, OTCQX, Woman, FBI, Triton Digital, Media Group, Female, Culture, Horn, Chemistry, Food, Radio Ink, Multimedia, Nextgen, Answer, Clothing

Salem Media Group , Inc. (OTCQX: SALM) announced today that the "Happy Women” podcast, hosted by Jennifer Horn and Katie Gorka will launch on the Salem Podcast Network on Tuesday, April 23rd, with two episodes released each week.

Key Points: 
  • Salem Media Group , Inc. (OTCQX: SALM) announced today that the "Happy Women” podcast, hosted by Jennifer Horn and Katie Gorka will launch on the Salem Podcast Network on Tuesday, April 23rd, with two episodes released each week.
  • View the full release here: https://www.businesswire.com/news/home/20240419872737/en/
    Katie Gorka and Jennifer Horn (Photo: Business Wire)
    “As we work hard to save America, we know women will be at the forefront.
  • I can’t wait to hear this podcast with two strong women who have great chemistry and rapport together,” said Salem Senior Vice President of Spoken Word, Phil Boyce.
  • "I am so excited to partner with Katie Gorka and the Salem Podcast Network on ‘Happy Women’”, said Jennifer Horn.

Vizgen Issued a New US Patent for Its MERFISH Technology

Retrieved on: 
Tuesday, April 16, 2024
Research, Patent Law, Genetics, Health Technology, Professional Services, Biotechnology, Health, Other Science, Science, United States patent law, RNA, Harvard College, Patent, Chemistry, PTAB, AACR, Harvard University, Inter partes review

Vizgen has secured key patents protecting its innovative pioneering technology in the United States and abroad, adding to its growing patent portfolio as Vizgen continues to invest in the development of its groundbreaking technologies.

Key Points: 
  • Vizgen has secured key patents protecting its innovative pioneering technology in the United States and abroad, adding to its growing patent portfolio as Vizgen continues to invest in the development of its groundbreaking technologies.
  • This newly allowed patent is owned by The President and Fellows of Harvard College and is exclusively licensed to Vizgen.
  • To date, there are over two hundred peer-reviewed and preprint publications on MERFISH technology and thousands of samples have been processed on MERSCOPE instruments.
  • During AACR 2024, Vizgen unveiled the MERSCOPE® Ultra Platform and shared new MERFISH 2.0 chemistry data.

Chemical Marketing & Economics Honors Celanese Chairman, CEO and President Lori J. Ryerkerk with STEM Leadership Award for Corporate Reinvention

Retrieved on: 
Tuesday, April 16, 2024
Technology, Engineering, Other Energy, Chemicals, Plastics, Other Technology, Manufacturing, Energy, Other Science, Science, Ecosystem, Celanese, CME, Corporation, Woman, STEM, Chemistry, Workforce, Overalls, CE, Management

Celanese Corporation (NYSE: CE) and Chemical Marketing & Economics, Inc. (CME) today announced that Lori J. Ryerkerk, chairman, chief executive officer and president of Celanese, will be the recipient of the CME STEM Leadership Award™ for Corporate Reinvention.

Key Points: 
  • Celanese Corporation (NYSE: CE) and Chemical Marketing & Economics, Inc. (CME) today announced that Lori J. Ryerkerk, chairman, chief executive officer and president of Celanese, will be the recipient of the CME STEM Leadership Award™ for Corporate Reinvention.
  • Ms. Ryerkerk will be honored at a reception and gala event on December 10, 2024, in New York City.
  • Celanese is a global leader in chemistry, producing specialty material solutions used across most major industries and consumer applications.
  • “Our people are the driving force behind our success, and it’s an honor to represent the collective hard work of the entire Celanese team who made this award possible,” said Lori Ryerkerk, CEO of Celanese.

Prague High School Selects Varsity Tutors for Schools to Provide Students with Additional Learning Resources

Retrieved on: 
Friday, April 12, 2024
Primary, Secondary, Education, Technology, Training, Family, Audio, Video, Internet, Consumer, Teens, Parenting, Continuing, Algebra, School, Chemistry, Student, Learning, Parent, Prague High School, Geometry, Biology, Tutoring

"Access to the Varsity Tutors for Schools platform can be an invaluable resource in those moments when students need assistance, but cannot get one-on-one time with their teacher, or when they’re looking for additional study materials that will help them succeed academically,” said Kim Fleak, principal at Prague High School.

Key Points: 
  • "Access to the Varsity Tutors for Schools platform can be an invaluable resource in those moments when students need assistance, but cannot get one-on-one time with their teacher, or when they’re looking for additional study materials that will help them succeed academically,” said Kim Fleak, principal at Prague High School.
  • “We’re excited to be augmenting everyday learning with the Varsity Tutors for Schools platform, and we encourage students to take advantage of all that it provides for them."
  • Over 500 school districts across the country utilize the Varsity Tutors for Schools platform to supplement classroom learning and to effectively close learning gaps.
  • “Varsity Tutors for Schools delivers a rich set of learning options to deploy for all students,” said Anthony Salcito, Chief Institutional Officer at Varsity Tutors for Schools.

Global Research Antibodies & Reagents Market Outlook & Forecasts, 2023 and 2024-2029: Growing Demand for Precision Medicine, Rising Focus on Biomarker Discovery, & Rise in Proteomics and Genomics - ResearchAndMarkets.com

Retrieved on: 
Friday, April 12, 2024
Health, Stem Cells, Genetics, Research, Science, Biotechnology, USD, Immunoprecipitation, Antibody, Cancer, Genomics, Protein, Cell biology, ELISA, Heart, Personalized medicine, Proteomics, Immunohistochemistry, Biomedical Research, Biomarker, Growth, University, Disease, ChromeOS, Bio-Rad Laboratories, Therapy, Northern blot, Patient, Chemistry, Medicine, Diagnosis, Antigen, Gene expression, Genome, Elisa's, Drug development, Biology, Molecular biology, Drug discovery, Thermo Fisher Scientific, Gene, Flow cytometry, Fine chemical

North America holds the most prominent share of the global research antibodies & reagents market, accounting for over 39% in 2023.

Key Points: 
  • North America holds the most prominent share of the global research antibodies & reagents market, accounting for over 39% in 2023.
  • This paradigm shift presents a substantial opportunity for the research antibodies & reagents market, an essential component of precision medicine research.
  • The reagents product type accounted for the most significant global research antibodies & reagents market share in 2023.
  • The academics & research institutes and research labs end-user segment dominated the global research antibodies & reagents market share in 2023.